KK Shah Hospitals Limited (BOM:544013)
India · Delayed Price · Currency is INR 39.00
0.00 (0.00%)
At close: Jul 30, 2026
KK Shah Hospitals Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Cash & Equivalents | 4.6 | 3.69 | 8.05 | 20.18 |
Cash & Short-Term Investments | 4.6 | 3.69 | 8.05 | 20.18 |
Cash Growth | 24.62% | -54.14% | -60.10% | - |
Accounts Receivable | 5.24 | 0.62 | 1.07 | 0.48 |
Other Receivables | 0.11 | 3.23 | 3.29 | - |
Receivables | 5.35 | 3.85 | 4.36 | 0.48 |
Prepaid Expenses | 0.53 | 0.04 | 0.6 | - |
Other Current Assets | 3.95 | 7.76 | 7.76 | 2.31 |
Total Current Assets | 14.43 | 15.33 | 20.77 | 22.97 |
Property, Plant & Equipment | 126.81 | 77.68 | 18.64 | 12.56 |
Long-Term Investments | 5.65 | 65.04 | 104.48 | 20.18 |
Other Intangible Assets | 0.32 | 0.4 | 0.3 | 0.35 |
Long-Term Deferred Tax Assets | 2.21 | 1.15 | 1.16 | - |
Other Long-Term Assets | 0.85 | 0.18 | 0.96 | 0.07 |
Total Assets | 150.26 | 159.77 | 146.31 | 56.13 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Accounts Payable | 18.27 | 21.87 | 1.63 | 1.02 |
Accrued Expenses | 3.93 | 3.48 | 1.63 | 3.14 |
Current Income Taxes Payable | - | - | 1.97 | 0.72 |
Current Unearned Revenue | 0.12 | 0.26 | 0.16 | 0.31 |
Other Current Liabilities | 0.01 | 0.01 | - | - |
Total Current Liabilities | 22.33 | 25.61 | 5.38 | 5.19 |
Long-Term Deferred Tax Liabilities | - | - | - | 0.02 |
Other Long-Term Liabilities | - | - | - | 0 |
Total Liabilities | 22.33 | 25.61 | 5.38 | 5.21 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Common Stock | 68.09 | 68.09 | 68.09 | 48.59 |
Additional Paid-In Capital | 64.5 | 64.5 | 64.59 | 0.16 |
Retained Earnings | -4.65 | 1.58 | 8.25 | 2.18 |
Comprehensive Income & Other | - | - | 0 | - |
Shareholders' Equity | 127.93 | 134.16 | 140.93 | 50.92 |
Total Liabilities & Equity | 150.26 | 159.77 | 146.31 | 56.13 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Net Cash (Debt) | 4.6 | 3.69 | 8.05 | 20.18 |
Net Cash Growth | 24.62% | -54.14% | -60.10% | - |
Net Cash Per Share | 0.68 | 0.54 | 1.42 | 4.15 |
Filing Date Shares Outstanding | 6.81 | 6.81 | 6.81 | 4.86 |
Total Common Shares Outstanding | 6.81 | 6.81 | 6.81 | 4.86 |
Working Capital | -7.9 | -10.28 | 15.38 | 17.77 |
Book Value Per Share | 18.79 | 19.70 | 20.70 | 10.48 |
Tangible Book Value | 127.62 | 133.76 | 140.63 | 50.57 |
Tangible Book Value Per Share | 18.74 | 19.65 | 20.65 | 10.41 |
Machinery | 95.98 | 92.33 | 17.08 | 13.53 |
Construction In Progress | 62.24 | - | 6.24 | - |